NewsRamp Science, Exploration and Discovery Podcast
Advancements in Biopharmaceuticals and Antibody Development
Aug 18, 2025
2:43
-(0)
About this episode
Soligenix Inc. receives FDA Orphan Drug Designation for dusquetide in Behçet’s Disease, showcasing positive Phase 2a results. On the other hand, Creative Biolabs offers specialized antibody QC services and a scholarship program for students in biology and related fields, emphasizing innovation in antibody development.
Comments
Rate this episode
Episode Details
- Author
- NewsRamp
- Show Type
- full
- Audio Format
- audio/mpeg